Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism

Participation Deadline: 06/30/2026
Apply Now

Description

This single-center, randomized, double-blind, placebo-controlled, parallel-group trial will evaluate pain and quality of life outcomes associated with 6 months of treatment with testosterone or placebo in men aged 18 years or older with chronic non-cancer spinal pain who are taking opioid analgesics for at least 6 months and have opioid-induced hypogonadism.